Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;49(6):5199-5208.
doi: 10.1007/s11033-022-07234-2. Epub 2022 Feb 25.

Role of non-coding RNAs in response of breast cancer to radiation therapy

Affiliations
Review

Role of non-coding RNAs in response of breast cancer to radiation therapy

Nastaran Masoudi-Khoram et al. Mol Biol Rep. 2022 Jun.

Abstract

Breast cancer ranks as the first common cancer with a high incidence rate and mortality among women. Radiation therapy is the main therapeutic method for breast cancer patients. However, radiation resistance of tumor cells can reduce the efficacy of treatment and lead to recurrence and mortality in patients. Non-coding RNA (ncRNAs) refers to a group of small RNA molecules that are not translated into protein, while they have the ability to modulate the translation of target mRNA. Several studies have reported the altered expression of ncRNAs in response to radiation in breast cancer. NcRNAs have been found to influence on radiation response of breast cancer by regulating various mechanisms, including DNA damage response, cell cycle regulation, cell death, inflammatory response, cancer stem cell and EGFR related pathways. This paper aimed to provide a summary of current findings on ncRNAs dysregulation after irradiation. We also present the function and mechanism of ncRNAs in modulating radiosensitivity or radioresistance of breast cancer cells.

Keywords: Breast cancer; Non-coding RNA; Radiation resistance; Signal transduction.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 71(3):209–249
    1. Chong ZX, Yeap SK, Ho WY (2021) Role of miRNAs in regulating responses to radiotherapy in human breast cancer. Int J Radiat Biol 97(3):289–301 - PubMed - DOI
    1. Yadav P, Shankar BS (2019) Radio resistance in breast cancer cells is mediated through TGF-β signalling, hybrid epithelial-mesenchymal phenotype and cancer stem cells. Biomed Pharmacother 111:119–130 - PubMed - DOI
    1. Kumar S, Gonzalez EA, Rameshwar P, Etchegaray J-P (2020) Non-coding RNAs as mediators of epigenetic changes in malignancies. Cancers 12(12):3657 - PMC - DOI
    1. O’Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne) 9:402. https://doi.org/10.3389/fendo.2018.00402 - DOI

LinkOut - more resources